The impact of benralizumab and dupilumab on exhaled volatile organic compound profiles of severe asthma patients – a preliminary analysis

S.M. Vassileva, S. Shahbazi Khamas, N. Dyhre-Petersen, S. Principe, S.J. Vijverberg, B. Hilvering, E.J.M. Weersink, A. Lillieroth Bricaud, E.J. Bari, A. Sverrild, P.A. Shah, A. Singapuri, M. Sereno, K. Ntotsis, G.W. Clarke, A. Azim, R. Chaudhuri, S.J. Fowler, F. Schleich, S. Siddiqui, L.I. Andersson, M. Kerr, E. Crone, M.J. Wilde, D.F. Lozano-Rojas, N. Quann, P.I. Bonta, J.T. Annema, C. Brightling, S.-E. Dahlén, C. Porsbjerg, A.H. Maitland-Van der Zee, P. Brinkman

Open source

DOI: 10.1016/j.rmed.2026.109067
Published: 2026-10
Container: Respiratory Medicine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.rmed.2026.109067,
  title = {The impact of benralizumab and dupilumab on exhaled volatile organic compound profiles of severe asthma patients – a preliminary analysis},
  author = {S.M. Vassileva and S. Shahbazi Khamas and N. Dyhre-Petersen and S. Principe and S.J. Vijverberg and B. Hilvering and E.J.M. Weersink and A. Lillieroth Bricaud and E.J. Bari and A. Sverrild and P.A. Shah and A. Singapuri and M. Sereno and K. Ntotsis and G.W. Clarke and A. Azim and R. Chaudhuri and S.J. Fowler and F. Schleich and S. Siddiqui and L.I. Andersson and M. Kerr and E. Crone and M.J. Wilde and D.F. Lozano-Rojas and N. Quann and P.I. Bonta and J.T. Annema and C. Brightling and S.-E. Dahlén and C. Porsbjerg and A.H. Maitland-Van der Zee and P. Brinkman},
  year = {2026},
  journal = {Respiratory Medicine},
  doi = {10.1016/j.rmed.2026.109067},
  url = {https://doi.org/10.1016/j.rmed.2026.109067}
}

RIS

TY  - JOUR
TI  - The impact of benralizumab and dupilumab on exhaled volatile organic compound profiles of severe asthma patients – a preliminary analysis
AU  - S.M. Vassileva
AU  - S. Shahbazi Khamas
AU  - N. Dyhre-Petersen
AU  - S. Principe
AU  - S.J. Vijverberg
AU  - B. Hilvering
AU  - E.J.M. Weersink
AU  - A. Lillieroth Bricaud
AU  - E.J. Bari
AU  - A. Sverrild
AU  - P.A. Shah
AU  - A. Singapuri
AU  - M. Sereno
AU  - K. Ntotsis
AU  - G.W. Clarke
AU  - A. Azim
AU  - R. Chaudhuri
AU  - S.J. Fowler
AU  - F. Schleich
AU  - S. Siddiqui
AU  - L.I. Andersson
AU  - M. Kerr
AU  - E. Crone
AU  - M.J. Wilde
AU  - D.F. Lozano-Rojas
AU  - N. Quann
AU  - P.I. Bonta
AU  - J.T. Annema
AU  - C. Brightling
AU  - S.-E. Dahlén
AU  - C. Porsbjerg
AU  - A.H. Maitland-Van der Zee
AU  - P. Brinkman
PY  - 2026
JO  - Respiratory Medicine
DO  - 10.1016/j.rmed.2026.109067
UR  - https://doi.org/10.1016/j.rmed.2026.109067
ER  -

APA

Vassileva, S., Khamas, S. S., Dyhre-Petersen, N., Principe, S., Vijverberg, S., Hilvering, B., Weersink, E., Bricaud, A. L., Bari, E., Sverrild, A., Shah, P., Singapuri, A., Sereno, M., Ntotsis, K., Clarke, G., Azim, A., Chaudhuri, R., Fowler, S., Schleich, F., Siddiqui, S., Andersson, L., Kerr, M., Crone, E., Wilde, M., Lozano-Rojas, D., Quann, N., Bonta, P., Annema, J., Brightling, C., Dahlén, S., Porsbjerg, C., Zee, A. M. D., & Brinkman, P. (2026). The impact of benralizumab and dupilumab on exhaled volatile organic compound profiles of severe asthma patients – a preliminary analysis. Respiratory Medicine. https://doi.org/10.1016/j.rmed.2026.109067

Source records

crossref · retrieved 2026-09-26T07:41:27.289Z